Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRI1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | PDCD4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | UCN2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | RBMS1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | TAS2R4 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | OGFRL1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | STMN3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | PPP1R1A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | FAM21A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | DBNL | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |